girentuximab
A chimeric monoclonal antibody directed against G250, a cell surface antigen found in the majority of renal cell carcinomas. Following binding, girentuximab may be internalized by G250 antigen-expressing renal carcinoma cells; mAb G250 may be useful as a carrier for radioisotopes and other antineoplastic therapeutic agents.
| Synonym: | chimeric monoclonal antibody cG250 monoclonal antibody G-250 WX-G250 |
|---|---|
| US brand name: | Rencarex |
| Abbreviation: | cG250 MOAB G250 |